Several other equities analysts also recently issued reports on UNH. Leerink Swann reaffirmed a buy rating on shares of UnitedHealth Group in a report on Friday, June 10th. Credit Suisse Group AG reaffirmed a buy rating on shares of UnitedHealth Group in a report on Friday, June 10th. Sanford C. Bernstein began coverage on shares of UnitedHealth Group in a report on Wednesday, June 15th. They set an outperform rating and a $171.00 price objective on the stock. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a report on Tuesday, June 21st. Finally, Wolfe Research began coverage on shares of UnitedHealth Group in a report on Tuesday, June 28th. They set an outperform rating and a $172.00 price objective on the stock. One analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group has a consensus rating of Buy and a consensus price target of $154.96.
UnitedHealth Group (NYSE:UNH) opened at 141.04 on Thursday. UnitedHealth Group has a one year low of $107.51 and a one year high of $144.48. The company’s 50-day moving average is $138.85 and its 200 day moving average is $135.18. The company has a market capitalization of $134.33 billion, a P/E ratio of 22.07 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The company had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. On average, equities analysts anticipate that UnitedHealth Group will post $7.92 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.77%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.65% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Van Hulzen Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC increased its stake in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares in the last quarter. MCF Advisors LLC increased its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares in the last quarter. Hanson McClain Inc. increased its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares in the last quarter. Finally, Howe & Rusling Inc. increased its stake in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock valued at $130,000 after buying an additional 40 shares in the last quarter. Institutional investors own 85.78% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.